日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2. 2. 15 cells by activating the JAK-STAT signaling pathway

更正:TMEM2 通过激活 JAK-STAT 信号通路抑制 HepG2 和 HepG2.2.15 细胞中的乙型肝炎病毒感染。

Zhu, X; Xie, C; Li, Y -M; Huang, Z -L; Zhao, Q -Y; Hu, Z -X; Wang, P -P; Gu, Y -R; Gao, Z -L; Peng, L

[Efficacy evaluation of extending or switching to tenofovir amibufenamide in patients with chronic hepatitis B: a phase Ⅲ randomized controlled study]

[慢性乙型肝炎患者延长或改用替诺福韦胺的疗效评价:一项Ⅲ期随机对照研究]

Liu, Z H; Jin, Q L; Zhang, Y X; Gong, G Z; Wu, G C; Yao, L F; Wen, X F; Gao, Z L; Huang, Y; Yang, D K; Chen, E Q; Mao, Q; Lin, S D; Shang, J; Gong, H Y; Zhong, L H; Yin, H F; Wang, F M; Hu, P; Zhang, X Q; Gao, Q J; Jin, C N; Li, C; Niu, J Q; Hou, J L

[Safety profile of tenofovir amibufenamide therapy extension or switching in patients with chronic hepatitis B: a phase Ⅲ multicenter, randomized controlled trial]

[替诺福韦胺治疗慢性乙型肝炎患者延长或转换治疗的安全性分析:一项Ⅲ期多中心随机对照试验]

Liu, Z H; Jin, Q L; Zhang, Y X; Gong, G Z; Wu, G C; Yao, L F; Wen, X F; Gao, Z L; Huang, Y; Yang, D K; Chen, E Q; Mao, Q; Lin, S D; Shang, J; Gong, H Y; Zhong, L H; Yin, H F; Wang, F M; Hu, P; Zhang, X Q; Gao, Q J; Xia, P; Li, C; Niu, J Q; Hou, J L

[Predictive factors for HBsAg-negative seroconversion in chronic hepatitis B after antiviral therapy]

[慢性乙型肝炎抗病毒治疗后HBsAg阴性血清转换的预测因素]

Wu, L L; Gao, Z L

[Therapeutic strategies, practice, and prospect of a clinical cure for chronic hepatitis B in China]

【中国慢性乙型肝炎的治疗策略、实践及临床治愈前景】

Mo, Z S; Xie, D Y; Lin, B L; Dou, X G; Wan, M B; Jiang, J J; Zhao, Y R; Tang, H; Zhuang, H; Gao, Z L

[Multi-omics combined test performance effectiveness on opportunistic screening of high-risk liver cancer population]

[多组学联合检测在肝癌高危人群机会性筛查中的性能有效性]

Xie, C; Lin, B L; Deng, H; Zhang, X H; Zhao, Q Y; Gao, Z L

[Analysis of clinical characteristics of persistent HBeAg positivity in patients with chronic hepatitis B treated with nucleos(t)ide analogues]

[核苷(酸)类似物治疗慢性乙型肝炎患者持续性HBeAg阳性的临床特征分析]

Peng, L P; Gan, W Q; Zheng, Y B; Chen, Y M; Liu, J; Wu, Z B; Gao, Z L

[Progress in the clinical cure of the population of inactive hepatitis B surface antigen carriers]

[乙型肝炎表面抗原携带者非活动性人群临床治愈进展]

Mo, Z S; Gao, Z L

[Research advances in the treatment of liver failure with mesenchymal stem cell-derived exosomes]

[间充质干细胞来源外泌体治疗肝衰竭的研究进展]

Luo, Q M; Zhu, S; Peng, L; Gao, Z L

[Clinical application of serum Golgi protein 73 in patients with chronic liver diseases]

【血清高尔基蛋白73在慢性肝病患者中的临床应用】

Liu, Y N; Yao, M J; Zheng, S J; Chen, X M; Liu, X Y; Hu, P; Ou, Q S; Dou, X G; Chen, H S; Duan, Z P; Hou, J L; Nan, Y M; Gao, Z L; Xu, X Y; Zhuang, H; Lu, F M